HomeTagsHeart Failure

Heart Failure

Vectorious Medical Technologies Begins the VECTOR-HF II Study of its Implantable In-Heart Sensor for Left Atrial Pressure-Guided Patient Self-Management of Heart Failure

Vectorious Medical Technologies advises for the first time, heart failure patients can have full visibility of their hearts’ LA pressure and self-adjust their medication to stop further deterioration and avoid hospitalizations.

VUNO Med®-DeepECG™ Designated as Breakthrough Device

VUNO Chairman Lee Yeha said, "VUNO will continue to deliver the value of AI to even more beneficiaries through a wide range of biosignal initiatives, including the use of ECG data with its significant potential for providing clues to serious heart-related diseases."

First Japanese Patients Randomized In Corvia Medical’s REDUCE LAP-HF II Global Clinical Trial For Heart Failure

REDUCE LAP-HF II Global Clinical Trial is a prospective, double-blind, sham-controlled clinical trial randomizing 608 HFpEF and HFmrEF patients in the US, EU, Australia, Japan and Canada.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version